Risk of thrombosis associated with antiphospholipid antibodies in immune thrombocytopenic Purpura: A single center retrospective study of 152 patients

Thromb Res. 2023 Jan:221:7-9. doi: 10.1016/j.thromres.2022.11.008. Epub 2022 Nov 18.

¹ Internal Medicine Department, Estaing University Hospital, CHU Clermont-Ferrand, Clermont-Ferrand, France.
² Internal Medicine Department, Estaing University Hospital, CHU Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, Institut Pascal, F-63000 Clermont-Ferrand, France.
³ Direction de la Recherche Clinique (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France.
⁴ Internal Medicine Department, Estaing University Hospital, CHU Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, Institut Pascal, F-63000 Clermont-Ferrand, France. Electronic address: mruivard@chu-clermontferrand.fr.

No abstract available

Keywords: Anticardiolipin antibodies; Antiphospholipid antibodies; Lupus anticoagulant; Purpura thrombocytopenic idiopathic; Thrombosis.

Publication types